secwatch.observer — SEC 8-K summary
======================================

Issuer:     SIGA TECHNOLOGIES INC (SIGA)
CIK:        0001010086
Form:       8-K
Filed at:   2023-09-06T23:59:59+00:00
Accession:  0001140361-23-042810
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SIGA appoints Dr. Jay K. Varma as EVP and Chief Medical Officer
---------------------------------------------------------------

- Dr. Varma appointed EVP and CMO, effective Sept 6, 2023; continues as board member.
- Annual base salary $750,000; guaranteed bonus of $750,000 for 2023 (pro-rated) and 2024.
- Initial term through Dec 31, 2024, with automatic one-year renewals unless notice given.
- Severance includes base salary continuation, pro-rata bonus, 12-month COBRA, and accelerated equity vesting on qualifying termination.
- Dr. Varma previously served on board since Nov 2022; former professor at Weill Cornell and CDC role in NYC COVID response.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1010086/000114036123042810/0001140361-23-042810-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1010086/000114036123042810/brhc20058500_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-042810

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer